NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...
1.7k Views
Recap on Celltrion Healthcare IPO Day - Retail Investors Turned Positive, Why?
Celltrion Healthcare (091990 KS)'s performance on its market debut day was a bit of a surprise. Of course, given that the IPO price was set at the...
357 Views
JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
671 Views
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
371 Views
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
538 Views